In 2003 the web site of
www.jouhoukoukai.com has handled some
on more than 4,200 keywords related to all aspects of
the Japanese pharmaceutical affairs. Listed below are
some of the top searches with comments and follow-up.
tens of generic versions of
pravastatin were introduced to the market. At present,
as many as 72 different products, brands and
registered in Japan.
The remarkable change in both the prescribing practice
and the public attitude toward CNS disorders is
highlighted by the continuous interest in the
innovative for Japan headache treatment.
Detailed information is
available in the "All Triptans in Japan" document from
the new JKS series "All in Japan" in the
JKS Document Store.
Mevalotin - Following the expiration of the
Japanese patent held by
after the approval in
Meiji Seika launched its new generation of quinolones
under the brand Sword, in Japan in December
2002.Inquiries regarding the approval documents (Approval
Review and SBA), current Package Insert and
other relevant documents should be sent to
Sandimun - The
latest formulations of the
cyclosporine were approved in Japan on behalf of
Nihon Ciba-Geigy KK in
June 2001 and
only lately challenged in the market by the
Fasudil - The
original product developed by
Asahi Kasei KK has attracted the attention after its successful
licensing-out in 2001 to Schering AG.
Inquiries regarding the product profile or the package
insert of Eril Injections S (the brand in
Japan) should be sent to
MHLW - The interest to
the regulatory authorities in Japan was strong in 2003
and we expect to further increase in 2004 in the light
and the deregulation process from April 2005. As until
now, JKS will continue to provide all of users with
regular updates of the
Japan Approval Database
and announcements on the most important changes with
the pharmaceutical authorities and regulations.
Overall, the keywords used by our
users profound insight into the interests of pharma,
biotech, medical device, healthcare, life sciences,
nutraceutical, cosmetics companies, consulting, market
research, legal and information service providers toward
the Japanese pharma and healthcare market. Jouhou Koukai
Services is firmly committed to take advantage of
this knowledge and insights to provide information,
intelligence and advise to our customers in 2004.